Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluating the Performance of AI in Evaluating Breast MRI Performed With Dose Reduction
Sponsor: University of Alabama at Birmingham
Summary
The purpose of this study is to evaluate the ability of AI to correctly aid in characterization of benign and malignant lesions even when a low dose of gadolinium is administered. This study is relevant for several reasons, most notably being the reduction of MRI dose and decreased gadolinium deposition in the brain. In addition, use of AI may provide increased sensitivity and specificity for the radiologist evaluating a breast MRI exam. Half of the population will have benign pathologies and the other half will have malignant pathologies.
Key Details
Gender
FEMALE
Age Range
18 Years - 99 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2021-07-14
Completion Date
2026-01-20
Last Updated
2026-07-01
Healthy Volunteers
No
Interventions
Standard of Care (SOC) gadolinium Breast MRI
Standard of Care (SOC) gadolinium Breast MRI
reduced 1/4 dose gadolinium Breast MRI with Artificial Intelligence (AI) to aid in evaluation.
reduced 1/4 dose gadolinium Breast MRI with Artificial Intelligence (AI) to aid in evaluation.
Locations (1)
The Kirklin Clinic
Birmingham, Alabama, United States